不同茵栀黄制剂佐治新生儿高胆红素血症疗效观察  

Effect of different administration of Yinzhihuang in neonates with hyperbilirubinemia

作　　者：姚君[1] 高忻[1] 张敏[1] 

机构地区：[1]安徽省合肥市第三人民医院,安徽合肥230022

出　　处：《安徽医药》2012年第1期98-100,共3页Anhui Medical and Pharmaceutical Journal

摘　　要：目的观察茵栀黄口服液与注射剂在治疗新生儿高胆红素血症中的疗效差异。方法在蓝光照射及常规治疗的基础上将113例新生儿高胆红素血症患儿分为茵栀黄口服和静脉治疗两组,观察其治疗前后血清总胆红素下降变化。结果茵栀黄口服组治疗前后血清总胆红素降幅(172.1±22.9)μmol.L-1,总有效率98.6%,茵栀黄静脉组治疗前后血清总胆红素降幅(180±58.1)μmol.L-1,总有效率95%,两组间比较差异无显著性意义(P>0.05)。结论茵栀黄口服液与静脉注射剂佐疗新生儿高胆红素血症疗效差异无显著性。Objective To investigate the differences of the effect of Yinzhihuang oral liquid and injection in the treatment of neonatal hyperbilirubinemia.Methods 113 neonates with hyperbilirubinemia were divided into Yinzhihuang oral liquid and intravenous treatment groups on the basis of Blue-ray irradiation,then the changes of the total number of bilirubin in serum before and after treatment were observed.Results Before and after treatment,the total serum bilirubin level was decreased by（172.1±22.9） μmol·L-1 on average in Yinzhihuang oral liquid group,with a total effective rate of 98.6%.The total serum bilirubin level was decreased by（180±58.1） μmol·L-1 on average in Yinzhihuang intravenous group,with a total effective rate of 95%.There was no significant difference between Yinzhihuang oral liquid group and intravenous injection group（P0.05）.Conclusion There is no efficacy difference between Yinzhihuang oral liquid and intravenousinjection in treating neonatal hyperbilirubinemia.

关 键 词：新生儿 高胆红素血症 茵栀黄口服液 茵栀黄注射液 

分 类 号：R272[医药卫生—中医儿科学]